Articles

Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707

Department of Hematology and Oncology, Okayama University Hospital, Japan
Department of Hematology and Oncology, Okayama University Hospital, Japan
Department of Hematologic Oncology, Shikoku Cancer Center, Ehime, Japan
Department of Hematology and Oncology, Japanese Red Cross Society Himeji Hospital, Hyogo, Japan
Department of Internal Medicine, Kaneda Hospital, Okayama, Japan
Department of Hematology and Immunology, Kanazawa Medical University Hospital, Ishikawa, Japan
Department of Hematology, National Hospital Organization Okayama Medical Center, Japan
Department of Hematology, Chugoku Central Hospital, Hiroshima, Japan
Department of Hematology, Ehime Prefectural Central Hospital, Ehime, Japan
Department of Internal Medicine, Sumitomo Besshi Hospital, Ehime, Japan
Department of Hematology, Hyogo Cancer Center, Hyogo, Japan
Department of Hematology and Oncology, Shimane University Hospital, Japan
Department of Hematology, Okayama Rosai Hospital, Nagoya, Japan
Division of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute, Nagoya, Japan
Department of Pathology, School of Medicine, Kurume University, Fukuoka, Japan
Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Japan
Department of Pathology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan
Department of Hematology and Oncology, Okayama University Hospital, Japan
Vol. 102 No. 12 (2017): December, 2017 https://doi.org/10.3324/haematol.2017.167742